More answers like this
GPT-5Oct 21, 2026openai/gpt-5-2025-08-07
Should AI development be paused or restricted?
Short answer: Yes—some AI work should be restricted, and temporary pauses should be used as a safety valve when concrete risk thresholds are crossed. A blanket, open‑ended pause on all AI development isn’t practical or desirable; a targeted, risk‑based approach is.
Why an across‑the‑board pause is a bad default
•It slows clear benefits (healthcare, accessibility, science) and can push development to less responsible actors or jurisdictions.
•It’s hard to coordinate globally and easy to evade.
•Risks are heterogeneous: most applications are low risk; a small subset are truly dangerous.
When a pause does make sense
•Independent evaluations show a model can meaningfully lower the barriers to severe harms (e.g., automated cyber‑intrusion, design of biological threats, scalable deception, or autonomous replication).
•Safety mitigations (guardrails, monitoring, containment) demonstrably don’t work yet.
•After a serious incident, until root causes are fixed and verified.
•When crossing predefined capability or compute thresholds without required evaluations complete.
Sensible restrictions to adopt now (tiered by risk)
•Pre‑deployment:
•Licensing for training and operating “frontier” models above defined compute/capability thresholds.
•Mandatory third‑party safety evaluations and red‑teaming focused on bio, cyber, critical infrastructure, and societal manipulation.
•Secure development standards: data provenance, model/weight access controls, audit logs, reproducible training records.
•Deployment controls:
•Gradual releases with staged access; rate limits; tool-use sandboxing; strict API policy enforcement.
•Content provenance (e.g., C2PA) and robust watermarking/fingerprinting where feasible.
•Age/identity or enterprise verification for high‑risk features (code execution, lab tools, autonomous agents).
•Incident reporting requirements and the ability to recall or hot‑patch models.
•Compute and market governance:
•Reporting of large training runs; monitoring of very large compute clusters; export controls for highest‑end chips where appropriate.
•Liability for negligent deployment that foreseeably enables severe harm.
•Openness with guardrails:
•Encourage open research and smaller/safer models; withhold or stage weight releases for models that fail red‑line evaluations unless mitigations neutralize the risks.
•Social/economic measures:
•Fund safety research and evals; invest in worker transition, education, and misuse prevention.
How to decide “pause vs proceed”: a practical framework
1)Define red‑line capabilities (e.g., autonomous replication, novel pathogen design assistance, scalable spear‑phishing/cyber exploitation).
2)Independent evals test for these and for general dangerous autonomy.
3)Go/No‑Go rules: if a model breaches a red line and mitigations don’t neutralize it, pause training/deployment until they do.
4)Mitigation obligations: implement containment, tool restrictions, and monitoring proportional to risk.
5)Continuous oversight: post‑deployment audits, incident reporting, and recall authority.
Bottom line: Don’t halt the entire field. Do require strong, enforceable safeguards; restrict and, when necessary, temporarily pause the small slice of work that creates outsized risk.
If you want, tell me your context (policymaker, lab, company, educator, etc.) and I can tailor a concrete checklist.